SEARCH

Current Edition

AstraZeneca

AstraZeneca builds case for long-acting COVID-19 drug, but is it too late?

In some ways, AstraZeneca’s COVID-19 response has been as good as any in the biopharmaceutical industry. The British drugmaker licensed and developed an effective COVID-19 …

Continue Reading →